Source: Annual Congress 2010 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Schreiber, C. Valerio, C. Handler, G. Keir, A. Wells, C. Denton, G. Coghlan (London, United Kingdom). Application of a formula to predict mean pulmonary artery pressures in patients with connective tissue disease. Eur Respir J 2010; 36: Suppl. 54, 3524

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020 Year: 2021 Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH) Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006 A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis Source: Eur Respir J, 51 (1) 1701311; 10.1183/13993003.01311-2017 Year: 2018 Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Rate of change in main pulmonary artery diameter predicts mortality in interstitial lung disease Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Prognostic value of right ventricular mass and function in connective tissue disease-associated pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1602493; 10.1183/13993003.02493-2016 Year: 2017 Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Dependence of mean pulmonary artery pressure from cytokine inflammation activity and remodeling index of pulmonary circulation Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Morphological and molecular alterations of pulmonary vasculature in a pig model with increased pulmonary blood flow and pressure compared to "pulmonary plexogenic arteriopathy" (PPA) in children Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment Source: Eur Respir Rev 2014; 23: 505-509 Year: 2014 The relation between pulmonary artery pressure on echocardiography and pulmonary artery diameter on CT scan in patients with interstitial lung diseases Source: Eur Respir J 2007; 30: Suppl. 51, 119s Year: 2007 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Sitaxsentan improves 6MW and hemodynamics in patients with pulmonary arterial hypertension (PAH) related to connective tissue disease (CTD) Source: Eur Respir J 2005; 26: Suppl. 49, 564s Year: 2005 Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007